Office of the 20th Aug. – Prof. gave the policy of Bangkok. cross vaccination “Sinovac-AstraZeneca” indicates that immunity increases by 78.65%, protects against Delta species.
Dr. Apisamai Srirangsan, Assistant Spokesperson for the Center for Epidemic Management of Coronavirus Disease 2019 (CCSA), said that from a study by the Department of Medical Sciences and Siriraj Hospital in cross-vaccination with 3 needles. or combination vaccines against delta strains Of the 125 participants in the study, group 1 received 2 doses of Sinovac vaccine with 24.31%, group 2 with 2 doses of Astrazeneca, found 76.52% in the group. In the 3rd sinovac 1st dose astrazeneca 2nd dose, 78.65 immunity was obtained, and the 4th group of healthcare workers received 2 synovac injections and 3 astra stimulation. Seneca Immunity went up to 271.7 percent.
“Public health emphasizes the policy of cross vaccination or alternate vaccination. With the first injection of Sinovac, astrazeneca needle 2, which at the BAAC meeting in Bangkok accepted this cross vaccination policy into practice. And the study found that immune stimulation with the use of cross vaccines. The results from the use of Sinovac and Astrazeneca vaccines were effective, with the interval between the 1st and 2nd doses of only 3 weeks, making them suitable for the context of infection in the epidemic situation of D. Lata that expands throughout the country at the moment, “Dr. Apisamai Said.-Thai News Agency.